CN Stock MarketDetailed Quotes
300511 Shanghai Xuerong Bio-Technology
- 4.47
- -0.02-0.45%
Trading Dec 16 14:11 CST
2.23BMarket Cap-9.96P/E (TTM)
4.63High4.47Low233.44KlotVolume4.47Open4.49Pre Close106.09MTurnover5.58%Turnover RatioLossP/E (Static)498.82MShares5.4452wk High1.69P/B1.87BFloat Cap2.4052wk Low5.39Limit Up418.04MShs Float27.00Historical High3.59Limit Down3.56%Amplitude2.40Historical Low--Dividend TTM4.54Avg Price111.18KlotAsk--Div YieldTTM100Lot Size119.98KlotBid
Shanghai Xuerong Bio-Technology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -15.56%1.64B | -22.11%1.07B | -28.30%603.99M | 10.55%2.57B | 17.83%1.94B | 41.22%1.37B | 46.27%842.41M | 12.49%2.32B | 15.40%1.65B | 4.82%973.54M |
| Operating revenue | -15.56%1.64B | -22.11%1.07B | -28.30%603.99M | 10.55%2.57B | 17.83%1.94B | 41.22%1.37B | 46.27%842.41M | 12.49%2.32B | 15.40%1.65B | 4.82%973.54M |
| Other operating revenue | ---- | -6.33%15.86M | ---- | 5.30%30.84M | ---- | 1.28%16.93M | ---- | 3.66%29.29M | ---- | 31.28%16.72M |
| Total operating cost | -12.48%1.81B | -7.80%1.22B | -1.54%602.08M | 16.72%2.7B | 22.75%2.07B | 19.63%1.32B | 16.58%611.5M | 4.42%2.31B | 5.73%1.69B | 6.44%1.11B |
| Operating cost | -7.56%1.6B | -4.36%1.07B | 0.66%525.61M | 13.42%2.35B | 16.68%1.73B | 13.84%1.12B | 14.15%522.19M | 6.03%2.07B | 5.09%1.49B | 8.60%979.59M |
| Operating tax surcharges | 6.07%16.23M | 8.70%11.2M | -2.81%5.05M | 9.09%20.54M | 4.97%15.3M | 2.73%10.3M | -2.37%5.2M | 12.82%18.83M | 21.18%14.57M | 32.23%10.03M |
| Operating expense | -69.95%22.12M | -65.69%15.66M | -50.59%8.27M | 259.95%80.24M | 405.20%73.62M | 408.67%45.64M | 231.32%16.74M | -3.78%22.29M | 1.05%14.57M | -8.71%8.97M |
| Administration expense | -46.00%96.57M | -42.53%64.71M | -33.50%30.28M | 41.09%160.27M | 83.14%178.83M | 89.95%112.61M | 40.98%45.54M | -14.00%113.6M | 9.75%97.65M | -23.06%59.28M |
| Financial expense | 13.73%71.28M | 65.47%59.98M | 56.90%31.35M | 4.10%83.98M | -8.12%62.68M | -20.22%36.25M | -11.34%19.98M | 4.62%80.67M | 28.10%68.22M | 30.26%45.43M |
| -Interest expense (Financial expense) | 16.45%74.73M | 21.84%51.42M | 21.58%25.2M | -4.50%88.77M | -11.64%64.17M | -13.86%42.21M | -11.85%20.72M | 20.56%92.96M | 34.69%72.62M | 36.95%49M |
| -Interest Income (Financial expense) | 67.05%-1.94M | 70.88%-1.44M | 73.58%-622.95K | 25.07%-7.16M | 9.02%-5.9M | -10.16%-4.95M | -41.77%-2.36M | -47.38%-9.55M | -25.30%-6.48M | -16.27%-4.49M |
| Research and development | -50.13%2.99M | -37.70%2.25M | -18.39%1.52M | -8.75%6.84M | 7.06%6M | 17.20%3.61M | 1.85%1.86M | -44.75%7.49M | -54.91%5.61M | -61.90%3.08M |
| Credit Impairment Loss | 51.05%-624.43K | 17.89%-408.73K | -274.17%-94.55K | -24.66%-3.86M | 37.46%-1.28M | 68.89%-497.78K | 123.88%54.29K | -274.36%-3.1M | -192.79%-2.04M | -176.42%-1.6M |
| Asset Impairment Loss | ---- | ---- | ---- | 85.34%-58.6M | 54.83%-416.11K | 55.87%-558.63K | ---- | -123.27%-399.79M | ---921.25K | ---1.27M |
| Other net revenue | 620.23%16.43M | 2,301.80%12.58M | 237.70%8.72M | 85.92%-53.59M | -90.65%2.28M | -109.05%-571.2K | -52.21%2.58M | -120.34%-380.63M | 117.37%24.4M | -49.12%6.31M |
| Fair value change income | ---- | ---- | ---- | ---3.76M | ---- | ---- | ---- | ---- | ---- | ---- |
| Invest income | ---- | ---- | ---- | -87.53%1.11M | -91.17%1.26M | 273.54%1.35M | 968.75%1.11M | 780.43%8.87M | 927.82%14.23M | -154.39%-777.62K |
| -Including: Investment income associates | ---- | ---- | ---- | 94.65%-406.36K | ---- | ---- | ---- | ---7.6M | ---- | ---- |
| Asset deal income | 321.29%8.37M | 251.74%8.19M | 813.73%6.33M | 154.86%497.89K | -603.72%-3.78M | -1,331.86%-5.4M | -590.28%-887.42K | 90.17%-907.5K | 95.75%-537.53K | 95.84%-376.84K |
| Other revenue | 33.65%8.69M | 5.87%4.8M | 7.62%2.48M | -22.86%11.03M | -52.47%6.5M | -56.13%4.53M | -64.36%2.3M | 11.95%14.29M | -32.62%13.68M | -42.44%10.33M |
| Operating profit | -23.79%-155.2M | -369.98%-136.92M | -95.45%10.62M | 49.25%-190.39M | -824.04%-125.38M | 140.07%50.71M | 311.07%233.49M | -14.79%-375.12M | 91.26%-13.57M | -28.83%-126.55M |
| Add:Non operating Income | -12.69%970.68K | 25.97%605.6K | -18.93%458.66K | -46.86%5.92M | -89.87%1.11M | -95.47%480.76K | 586.67%565.76K | 56.87%11.14M | 74.60%10.97M | 83.02%10.61M |
| Less:Non operating expense | -49.72%1.09M | -46.00%796.87K | -18.90%377.81K | -53.94%7.63M | -47.39%2.17M | 127.66%1.48M | 98.88%465.84K | 0.81%16.56M | 233.46%4.13M | -45.97%648.23K |
| Total profit | -22.84%-155.33M | -375.77%-137.11M | -95.42%10.7M | 49.52%-192.1M | -1,779.68%-126.44M | 142.65%49.72M | 312.35%233.59M | -13.21%-380.55M | 95.52%-6.73M | -24.51%-116.59M |
| Less:Income tax cost | -99.98%66.28 | -99.99%39.39 | -99.99%18.5 | -98.27%235.08K | -6.94%269.99K | 105.33%268.57K | 107.10%275.43K | 401.83%13.57M | 104.47%290.13K | -37.94%-5.04M |
| Net profit | -22.58%-155.33M | -377.26%-137.11M | -95.41%10.7M | 51.20%-192.33M | -1,705.81%-126.71M | 144.33%49.45M | 285.47%233.31M | -18.84%-394.12M | 95.12%-7.02M | -23.97%-111.54M |
| Net profit from continuing operation | -22.58%-155.33M | -377.26%-137.11M | -95.41%10.7M | 51.20%-192.33M | -1,705.81%-126.71M | 144.33%49.45M | 285.47%233.31M | -18.84%-394.12M | 95.12%-7.02M | -23.97%-111.54M |
| Less:Minority Profit | 551.30%8.48M | -21.93%6.49M | -48.48%5.46M | 96.00%-4.27M | 109.83%1.3M | 177.44%8.31M | 238.72%10.6M | -170.17%-106.89M | 53.31%-13.25M | 44.33%-10.73M |
| Net profit of parent company owners | -27.96%-163.81M | -449.04%-143.59M | -97.65%5.24M | 34.52%-188.06M | -2,154.30%-128.01M | 140.81%41.14M | 288.02%222.71M | 1.66%-287.23M | 105.40%6.23M | -42.59%-100.81M |
| Earning per share | ||||||||||
| Basic earning per share | -26.92%-0.33 | -462.50%-0.29 | -97.78%0.01 | 35.59%-0.38 | -2,700.00%-0.26 | 138.10%0.08 | 246.15%0.45 | 13.24%-0.59 | 103.70%0.01 | -31.25%-0.21 |
| Diluted earning per share | -26.92%-0.33 | -462.50%-0.29 | -97.78%0.01 | 35.59%-0.38 | -2,700.00%-0.26 | 142.11%0.08 | 246.15%0.45 | 11.94%-0.59 | 103.70%0.01 | -18.75%-0.19 |
| Other composite income | -36.21%387.94K | 116.52%150.33K | 6,365.38%1.42M | -40.47%-1.12M | 146.88%608.19K | -328.74%-910.02K | 109.91%22K | 93.18%-795.1K | 89.21%-1.3M | 96.78%-212.25K |
| Other composite income of parent company owners | -22.08%276.41K | 105.41%42.22K | 6,151.71%825.14K | -40.95%-672.42K | 145.58%354.74K | -512.62%-780.17K | 109.91%13.2K | 93.18%-477.06K | 88.74%-778.37K | 96.83%-127.35K |
| Other composite income of minority owners | -55.99%111.53K | 183.26%108.11K | 6,685.90%597.1K | -39.76%-444.48K | 148.84%253.44K | -52.94%-129.85K | 109.91%8.8K | 93.18%-318.04K | 89.85%-518.91K | 96.70%-84.9K |
| Total composite income | -22.87%-154.94M | -382.15%-136.96M | -94.80%12.13M | 51.01%-193.45M | -1,416.73%-126.1M | 143.43%48.54M | 286.92%233.33M | -15.03%-394.91M | 94.66%-8.31M | -15.73%-111.76M |
| Total composite income of parent company owners | -28.10%-163.53M | -455.68%-143.55M | -97.28%6.07M | 34.40%-188.73M | -2,441.02%-127.66M | 139.98%40.36M | 288.94%222.72M | 3.80%-287.7M | 104.46%5.45M | -35.10%-100.94M |
| Total composite income of minority owners | 452.39%8.6M | -19.37%6.6M | -42.89%6.06M | 95.60%-4.72M | 111.30%1.56M | 175.63%8.18M | 248.90%10.61M | -142.40%-107.21M | 58.89%-13.77M | 50.50%-10.82M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
